Genaera Corporation Begins Phase 1b Trial of Trodusquemine (MSI ...

Posted in Diabetes management protocol on Mon, 01 Dec 2008 12:26:57 -0800

Genaera Corporation is developing trodusquemine (MSI-1436), for type 2 diabetes and obesity currently in Phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in Phase 2 clinical testing in ... Living with Diabetes

Original article: Genaera Corporation Begins Phase 1b Trial of Trodusquemine (MSI ... by at diabetes management protocol - Google Blog Search


Tags: